OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis
Christina Nalkurthi, Wayne A. Schroder, Michelle Melino, et al.
JHEP Reports (2021) Vol. 4, Iss. 1, pp. 100386-100386
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Preclinical to clinical utility of ROCK inhibitors in cancer
Jaume Barcelo, Rémi Samain, Victoria Sanz‐Moreno
Trends in cancer (2023) Vol. 9, Iss. 3, pp. 250-263
Open Access | Times Cited: 61

Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis
Liang Shan, Fengling Wang, Dandan Zhai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114472-114472
Open Access | Times Cited: 48

Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models
Devaraj Ezhilarasan
Environmental Toxicology and Pharmacology (2023) Vol. 99, pp. 104093-104093
Closed Access | Times Cited: 43

Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3
Qingfang Li, Yuan Cheng, Zhe Zhang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 10
Open Access | Times Cited: 48

Mechanobiology of portal hypertension
Éric Felli, Sonia Selicean, Sergi Guixé‐Muntet, et al.
JHEP Reports (2023) Vol. 5, Iss. 11, pp. 100869-100869
Open Access | Times Cited: 24

Macrophages as key regulators of liver health and disease
Eleni Papachristoforou, Prakash Ramachandran
International review of cell and molecular biology (2022), pp. 143-212
Closed Access | Times Cited: 32

Human umbilical cord/placenta mesenchymal stem cell conditioned medium attenuates intestinal fibrosis in vivo and in vitro
Yoon Jeong Choi, Woo Ram Kim, Duk Hwan Kim, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8

3-Indolepropionic acid prevented chlorpyrifos-induced hepatorenal toxicities in rats by improving anti-inflammatory, antioxidant, and pro-apoptotic responses and abating DNA damage
Solomon E. Owumi, Eseroghene S. Najophe, Moses T. Otunla
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 49, pp. 74377-74393
Closed Access | Times Cited: 22

Di-n-butyl phthalate induces oversecretion of vascular endothelium-derived NAP-2 and promotes epithelial-mesenchymal transition of urothelial cells in newborn hypospadias rats
Shan Hua, Fei Shi, Zhiwen Xie, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 256, pp. 114892-114892
Open Access | Times Cited: 11

ROCK2 regulates microglia proliferation and neuronal survival after traumatic brain injury
Emily F. Willis, Seung Jae Kim, Wei Chen, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 181-194
Open Access | Times Cited: 4

Suv39h1 contributes to activation of hepatic stellate cells in non-alcoholic fatty liver disease by enabling anaerobic glycolysis
Xiaoyan Wu, Yuzhou Shen, Yufei Meng, et al.
Life Sciences (2024) Vol. 341, pp. 122498-122498
Closed Access | Times Cited: 4

Fasudil attenuates oxidative stress-induced partial epithelial-mesenchymal transition of tubular epithelial cells in hyperuricemic nephropathy via activating Nrf2
Yun Cao, Yanni Wang, Weiwei Li, et al.
European Journal of Pharmacology (2024) Vol. 975, pp. 176640-176640
Open Access | Times Cited: 4

Timosaponin A-III Alleviates Asthma-Induced Airway Inflammation, Th17 Cell Differentiation, and STAT3/RORγt Pathway
Lijie Wang, Jiabo Yuan, Ruiqi Zhao, et al.
Immunological Investigations (2025), pp. 1-16
Closed Access

Identification of novel Kv1.3 channel-interacting proteins using proximity labelling in T-cells
Dilpreet Kour, Christine A Bowen, Upasna Srivastava, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Hepatocyte Rho-associated kinase signaling is required for mice to survive experimental porphyria-associated liver injury
Jessica M. Herrera, Yun Weng, Tyler J. Lieberthal, et al.
Hepatology Communications (2025) Vol. 9, Iss. 2
Open Access

Mechanosignaling via Integrins: Pivotal Players in Liver Fibrosis Progression and Therapy
Aigul Sharip, Jeannette Kunz
Cells (2025) Vol. 14, Iss. 4, pp. 266-266
Open Access

Unraveling the complexities of fibrosis and ductular reaction in liver disease: pathogenesis, mechanisms, and therapeutic insights
Corinn N. Marakovits, Heather Francis
AJP Cell Physiology (2023) Vol. 326, Iss. 3, pp. C698-C706
Closed Access | Times Cited: 9

SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis
Huimin Liu, Linbo Yue, Wenxuan Hong, et al.
Life Sciences (2024) Vol. 347, pp. 122605-122605
Closed Access | Times Cited: 3

Mechanosensory feedback loops during chronic inflammation
Sarbari Saha, Dafne Müller, Andrew G. Clark
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 8

Selectivity matters: selective ROCK2 inhibitor ameliorates established liver fibrosis via targeting inflammation, fibrosis, and metabolism
Alexandra Zanin‐Zhorov, Wei Chen, Julien Moretti, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 8

Transcriptomic evaluation of N6-methyladenosine modification can be used to identify differentially gene and immune-related biological processes in TX mice with liver fibrosis
Lili Zhang, Xiaofeng Huang, Dan Wang, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2

Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies
Joe Nguyen, Maryam Jessri, Ana Caroline Costa-da-Silva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10411-10411
Open Access | Times Cited: 2

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
Nataliya P. Buxbaum, Gèrard Socié, Geoffrey R. Hill, et al.
Blood Advances (2022) Vol. 7, Iss. 17, pp. 4886-4902
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top